An alternative explanation for the conflicting results regarding EAAT2 levels and glutamate uptake may be that other transporters—for example, EAAT3—are responsible for the increased glutamate uptake in MS tissues. The gene discussed is SLC1A2; the disease is myeloid sarcoma.